“Possibility of a re-invasion in early December… The recent increase in the number of confirmed cases in Europe”
“Vulnerable people should receive additional doses of COVID-19 vaccine”
Improved vaccine against sub-mutation of Omicron, approved for the first time in Korea
[앵커]
The number of new COVID-19 patients has stopped declining and is stagnant.
In early December, the possibility of a resurgence appears, and an improved vaccine for the Omicron sub-mutant virus, which is the dominant species, will soon be introduced in Korea.
Reporter Yoon-Jeong Shin reports.
[기자]
The number of new COVID-19 cases recorded 1,040.
Although the number of people decreased by 10,000 from the previous day, the number increased by about 2,000 from a week ago, which was the Hangeul Day holiday, and recorded an increase from the previous week for 4 days in a row.
It stopped the decline and entered a plateau,
It is predicted that the number of patients will not decrease further than now, which is an average of about 22,000 a day.
[정기석 / 코로나19 특별대응단장 : 주간 일 평균 2만 명대가 아마도 이번 겨울의 가장 바닥이 아니겠냐는 생각이 들고요. 앞으로는 조금씩 더 늘어나는 추세로 갈 것이다….]
Then, in early December, there was a possibility that a full-fledged re-fashion would come again.
This is because the number of confirmed cases is increasing again recently despite the high vaccination rates in Europe, such as Germany and France, which showed a trend of epidemics a month or two ahead of us.
The problem is that by the beginning of December, only 25% of the people have immunity.
[정기석 / 코로나19 특별대응단장 : 백신에 의한 것, 감염에 의한 것을 다 합쳐도 전체 인구 중에서 면역력을 갖고 있는 비율이 25%밖에 안 됩니다. 그래서 이 정도 가지고는 60세 이상을 보호할 수가 없습니다.]
In preparation for this, Director Jeong Ki-seok urged the last vaccination before August or additional vaccinations for vulnerable groups such as the elderly who were infected with Corona 19 before June.
In the midst of this, vaccine options have become even wider.
An improved vaccine developed to respond to BA.5, a sub-mutation of Omicron, which is the predominant species detected in more than 90% of confirmed cases in Korea, has recently been approved for emergency use.
The government has decided to announce a plan to boost Pfizer’s bivalent vaccine at the end of this month for people over the age of 13.
This is YTN Shin Yoon-jung.
YTN Yunjeong Shin ([email protected])
※ ‘Your report becomes news’
[카카오톡] Search YTN to add a channel
[전화] 02-398-8585
[메일] [email protected]
[저작권자(c) YTN 무단전재 및 재배포 금지]